| Meta-analysis summary statistics for associations meeting genome-wide significance | |||||||
|---|---|---|---|---|---|---|---|
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs9635324 | propionylcarnitine / isovalerylcarnitine | A/G | 7340 | 0.61 | -0.036 (0.003) | 8.75·10-43 | show |
| rs9635324 | isovalerylcarnitine | A/G | 7344 | 0.61 | 0.034 (0.003) | 1.89·10-35 | show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations | |
|---|---|
| SNP | rs9635324 |
| Chromosomal location | Chr15: 38,490,503 (15q15.1) |
| Gene (distance) | IVD (0) |
| Predicted causal gene | IVD |
| Gene/protein classification | - |
| Metabolite (Pathway) | propionylcarnitine (Fatty acid metabolism (also BCAA metabolism); Lipid) isovalerylcarnitine (Valine, leucine and isoleucine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | IVD encodes isovaleryl-CoA dehydrogenase which acts isovaleryl-CoA in the in the third step of leucine catabolism [3597357]. Acyl-CoAs and acyl-carnitines are readily interconverted. Ratio interpretation: IVD acts on isovaleryl-CoA but not propionyl-CoA ('normalizing') |
| eQTL associations | IVD (F), IVD (L), IVD (S), DISP2 (F), DISP2 (S) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information | |
|---|---|
| Complex trait associations | - |
| Known metabolite associations | 3-(4-hydroxyphenyl)lactate/isovalerylcarnitine [21886157] |
| Inborn error of metabolism | Isovaleric acidemia |
| Pharmacological information | |
|---|---|
| ChEMBL ID | - |
| Drug information | - |
| Locus information for top associated metabolite | |
|---|---|
HapMap2 imputation![]() | 1KGP imputation![]() |








